探索纳米载体作为皮肤癌治疗方法
Mohammad Adnan1, Md Habban Akhter2, Obaid Afzal3
1Faculty of Pharmacy, Integral University, Lucknow 226026, Uttar Pradesh, India.
Molecules (Basel, Switzerland)
|August 12, 2023
概括
纳米粒子为皮肤癌提供了一个有希望的局部治疗方法,增强药物输送和吸收. 这种纳米技术方法提高了治疗效率,并减少了非黑色素瘤皮肤癌 (NMSC) 的副作用.
科学领域:
- * 皮肤病学和纳米技术
- * 瘤学和制药科学 * 瘤学和制药科学
背景情况:
- * 皮肤癌,包括非黑色素瘤皮肤癌 (NMSC),是全球日益严重的健康问题.
- * 传统的局部治疗NMSC面临挑战,如生物可用性差和不稳定的吸收.
- * 黑色素瘤和非黑色素瘤 (基础细胞癌和皮肤状细胞癌) 占皮肤癌的95%.
研究的目的:
- * 审查用于局部皮肤癌治疗的基于纳米粒子的药物输送系统.
- * 探索纳米技术在克服传统治疗方法的局限性方面的潜力.
- * 评估各种纳米载体在改善皮肤癌治疗结果方面的有效性.
主要方法:
- *对用于皮肤癌治疗的纳米粒子制剂现有文献的综述.
- *对不同纳米载体系统的分析,包括脂质体,体,以体,转移体,转移体和纳米乳液.
- *评估纳米载体的透和在皮肤层内的药物输送.
主要成果:
- * 基于纳米粒子的系统显示了改善的局部输送和更深入地透到皮肤层.
- * 与传统配方相比,纳米载体显著提高了药物的生物可用性.
- *这些系统显示出降低剂量频率和相关毒性的潜力.
结论:
- *纳米技术为局部皮肤癌治疗提供了一种优越的策略.
- *纳米粒子输送系统有效向皮肤癌细胞,改善治疗反应.
- * 对纳米载体的进一步研究可以导致更有效,更安全的皮肤癌治疗.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


